These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35975297)

  • 1. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
    Schnittman SR; Lu MT; Mayrhofer T; Burdo TH; Fitch KV; McCallum S; Fulda ES; Zanni MV; Foldyna B; Malvestutto C; Fichtenbaum CJ; Aberg JA; Bloomfield GS; Overton ET; Currier J; Tebas P; Sha BE; Ribaudo HJ; Flynn JM; Douglas PS; Erlandson KM; Grinspoon SK
    Clin Infect Dis; 2023 Feb; 76(3):e613-e621. PubMed ID: 35975297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
    Hoffmann U; Lu MT; Foldyna B; Zanni MV; Karady J; Taron J; Zhai BK; Burdo T; Fitch KV; Kileel EM; Williams K; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg J; Currier J; Sponseller CA; Melbourne K; Floris-Moore M; Van Dam C; Keefer MC; Koletar SL; Douglas PS; Ribaudo H; Mayrhofer T; Grinspoon SK;
    JAMA Netw Open; 2021 Jun; 4(6):e2114923. PubMed ID: 34185068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
    Foldyna B; Mayrhofer T; Zanni MV; Lyass A; Barve R; Karady J; McCallum S; Burdo TH; Fitch KV; Paradis K; Fulda ES; Diggs MR; Bloomfield GS; Malvestutto CD; Fichtenbaum CJ; Aberg JA; Currier JS; Ribaudo HJ; Hoffmann U; Lu MT; Douglas PS; Grinspoon SK
    Clin Infect Dis; 2023 Dec; 77(12):1676-1686. PubMed ID: 37439633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV.
    Abidi MZ; Umbleja T; Overton ET; Burdo T; Flynn JM; Lu MT; Taron J; Schnittman SR; Fitch KV; Zanni MV; Fichtenbaum CJ; Malvestutto C; Aberg JA; Fulda ES; Eckard AR; Manne-Goehler J; Tuan JJ; Ribaudo HJ; Douglas PS; Grinspoon SK; Brown TT; Erlandson KM
    J Acquir Immune Defic Syndr; 2024 Apr; 95(5):470-478. PubMed ID: 38180893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
    Lu MT; Ribaudo H; Foldyna B; Zanni MV; Mayrhofer T; Karady J; Taron J; Fitch KV; McCallum S; Burdo TH; Paradis K; Hedgire SS; Meyersohn NM; DeFilippi C; Malvestutto CD; Sturniolo A; Diggs M; Siminski S; Bloomfield GS; Alston-Smith B; Desvigne-Nickens P; Overton ET; Currier JS; Aberg JA; Fichtenbaum CJ; Hoffmann U; Douglas PS; Grinspoon SK;
    JAMA Cardiol; 2024 Apr; 9(4):323-334. PubMed ID: 38381407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
    Douglas PS; McCallum S; Lu MT; Umbleja T; Fitch KV; Foldyna B; Zanni MV; Fulda ES; Bloomfield GS; Fichtenbaum CJ; Overton ET; Aberg JA; Malvestutto CD; Burdo TH; Arduino RC; Ho KS; Yin MT; Ribaudo HJ; Grinspoon SK
    AIDS; 2023 Mar; 37(3):423-434. PubMed ID: 36525544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.
    Hoffmann U; Lu MT; Olalere D; Adami EC; Osborne MT; Ivanov A; Aluru JS; Lee S; Arifovic N; Overton ET; Fichtenbaum CJ; Aberg JA; Alston-Smith B; Klingman KL; Waclawiw M; Burdo TH; Williams KC; Zanni MV; Desvigne-Nickens P; Cooper-Arnold K; Fitch KV; Ribaudo H; Douglas PS; Grinspoon SK;
    Am Heart J; 2019 Jun; 212():1-12. PubMed ID: 30928823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
    Kolossváry M; deFilippi C; Lu MT; Zanni MV; Fulda ES; Foldyna B; Ribaudo H; Mayrhofer T; Collier AC; Bloomfield GS; Fichtenbaum C; Overton ET; Aberg JA; Currier J; Fitch KV; Douglas PS; Grinspoon SK
    J Infect Dis; 2022 Nov; 226(10):1809-1822. PubMed ID: 35535576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
    Zou RS; Ruan Y; Truong B; Bhattacharya R; Lu MT; Karády J; Bernardo R; Finneran P; Hornsby W; Fitch KV; Ribaudo HJ; Zanni MV; Douglas PS; Grinspoon SK; Patel AP; Natarajan P
    J Am Heart Assoc; 2024 Apr; 13(7):e033413. PubMed ID: 38533953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
    Zanni MV; Foldyna B; McCallum S; Burdo TH; Looby SE; Fitch KV; Fulda ES; Autissier P; Bloomfield GS; Malvestutto CD; Fichtenbaum CJ; Overton ET; Aberg JA; Erlandson KM; Campbell TB; Ellsworth GB; Sheth AN; Taiwo B; Currier JS; Hoffmann U; Lu MT; Douglas PS; Ribaudo HJ; Grinspoon SK
    Clin Infect Dis; 2023 Jan; 76(2):323-334. PubMed ID: 36101518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Letendre S; Bharti A; Perez-Valero I; Hanson B; Franklin D; Woods SP; Gianella S; de Oliveira MF; Heaton RK; Grant I; Landay AL; Lurain N;
    Clin Infect Dis; 2018 Aug; 67(5):770-777. PubMed ID: 29506084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV.
    deFilippi C; McCallum S; Zanni MV; Fitch KV; Diggs MR; Bloomfield GS; Fichtenbaum CJ; Aberg JA; Malvestutto CD; Pinto-Martinez A; Stapleton A; Duggan J; Robbins GK; Taron J; Karady J; Foldyna B; Lu MT; Ribaudo HJ; Douglas PS; Grinspoon SK
    JACC Adv; 2024 Sep; 3(9):101206. PubMed ID: 39253712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    Patel EU; Gianella S; Newell K; Tobian AA; Kirkpatrick AR; Nalugoda F; Grabowski MK; Gray RH; Serwadda D; Quinn TC; Redd AD; Reynolds SJ
    AIDS; 2017 Mar; 31(6):807-813. PubMed ID: 28121712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls.
    Ramendra R; Isnard S; Lin J; Fombuena B; Ouyang J; Mehraj V; Zhang Y; Finkelman M; Costiniuk C; Lebouché B; Chartrand-Lefebvre C; Durand M; Tremblay C; Ancuta P; Boivin G; Routy JP
    Clin Infect Dis; 2020 Sep; 71(6):1438-1446. PubMed ID: 31608409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.
    Parrinello CM; Sinclair E; Landay AL; Lurain N; Sharrett AR; Gange SJ; Xue X; Hunt PW; Deeks SG; Hodis HN; Kaplan RC
    J Infect Dis; 2012 Jun; 205(12):1788-96. PubMed ID: 22492856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
    PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations.
    Karady J; Lu MT; Bergström G; Mayrhofer T; Taron J; Foldyna B; Paradis K; McCallum S; Aberg JA; Currier JS; Fitch KV; Fulda ES; Bloomfield GS; Overton ET; Lind L; Östgren CJ; Elvstam O; Söderberg S; Jernberg T; Pepe R; Dubé MP; Mushatt D; Fichtenbaum CJ; Malvestutto C; Zanni MV; Hoffmann U; Ribaudo H; Grinspoon SK; Douglas PS
    JACC Adv; 2024 Jun; 3(6):100968. PubMed ID: 38938873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.
    Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H
    Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events.
    Gianella S; Moser C; Vitomirov A; McKhann A; Layman L; Scott B; Caballero G; Lada S; Bosch RJ; Hoenigl M; Lurain N; Landay A; Lederman MM; Hunt PW; Smith D
    AIDS; 2020 May; 34(6):849-857. PubMed ID: 32271250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.